Publication | Closed Access

French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID) - Position statement from the European Society of Gene Therapy (ESGT)

Primary ImmunodeficiencyGene TherapiesTranslational MedicineImmune DeficiencyAutoimmune DiseaseIn Vivo Gene TherapyNovel TherapyImmunologyClinical TrialsTherapeutic EfficacyPosition StatementImmunologic DiseaseImmunotherapyMedicineRadiation OncologyInborn Error Of ImmunityHealth Sciences